fanta.bio Sample: CNhs10867
15914 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 944 / 9463 (10.0%) | 310 / 94630 (0.3%) | −324.0 | −324.0 | 30.45 |
| HIF1A SRX11007095 | HK-2 Kidney | 1727 / 9463 (18.3%) | 632 / 94630 (0.7%) | −324.0 | −324.0 | 27.33 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1329 / 9463 (14.0%) | 522 / 94630 (0.6%) | −324.0 | −324.0 | 25.46 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1308 / 9463 (13.8%) | 564 / 94630 (0.6%) | −324.0 | −324.0 | 23.19 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 1822 / 9463 (19.3%) | 804 / 94630 (0.8%) | −324.0 | −324.0 | 22.66 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 1765 / 9463 (18.7%) | 787 / 94630 (0.8%) | −324.0 | −324.0 | 22.43 |
| FOXP1 SRX736067 | LNCAP Prostate | 1485 / 9463 (15.7%) | 741 / 94630 (0.8%) | −324.0 | −324.0 | 20.04 |
| SCML2 SRX644728 | 293 Kidney | 1017 / 9463 (10.7%) | 520 / 94630 (0.5%) | −324.0 | −324.0 | 19.56 |
| MYH11 SRX265221 | ME-1 Blood | 674 / 9463 (7.1%) | 389 / 94630 (0.4%) | −324.0 | −324.0 | 17.33 |
| MED1 SRX9419945 | BT-474 Breast | 2357 / 9463 (24.9%) | 1817 / 94630 (1.9%) | −324.0 | −324.0 | 12.97 |
| BRD4 SRX9419937 | BT-474 Breast | 2342 / 9463 (24.7%) | 1831 / 94630 (1.9%) | −324.0 | −324.0 | 12.79 |
| MED1 SRX9419944 | BT-474 Breast | 2309 / 9463 (24.4%) | 1806 / 94630 (1.9%) | −324.0 | −324.0 | 12.79 |
| BRD4 SRX9419935 | BT-474 Breast | 2352 / 9463 (24.9%) | 1848 / 94630 (2.0%) | −324.0 | −324.0 | 12.73 |
| BRD4 SRX9419936 | BT-474 Breast | 2372 / 9463 (25.1%) | 1893 / 94630 (2.0%) | −324.0 | −324.0 | 12.53 |
| MED1 SRX9419946 | BT-474 Breast | 2381 / 9463 (25.2%) | 1934 / 94630 (2.0%) | −324.0 | −324.0 | 12.31 |
| BRD4 SRX9419938 | BT-474 Breast | 2352 / 9463 (24.9%) | 1912 / 94630 (2.0%) | −324.0 | −324.0 | 12.30 |
| MED1 SRX9419947 | BT-474 Breast | 2310 / 9463 (24.4%) | 1889 / 94630 (2.0%) | −324.0 | −324.0 | 12.23 |
| EZH2 SRX2146136 | LNCAP Prostate | 5057 / 9463 (53.4%) | 5201 / 94630 (5.5%) | −324.0 | −324.0 | 9.72 |
| BRD4 SRX736201 | 90-8TL Neural | 3935 / 9463 (41.6%) | 4226 / 94630 (4.5%) | −324.0 | −324.0 | 9.31 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1204 / 9463 (12.7%) | 1620 / 94630 (1.7%) | −324.0 | −324.0 | 7.43 |
| TP53 SRX19538279 | Osteoblasts Bone | 430 / 9463 (4.5%) | 181 / 94630 (0.2%) | −299.1 | −295.9 | 23.76 |
| HIF1A SRX20663235 | HK-2 Kidney | 397 / 9463 (4.2%) | 172 / 94630 (0.2%) | −273.6 | −270.4 | 23.08 |
| TP53 SRX19538274 | U2OS Bone | 352 / 9463 (3.7%) | 133 / 94630 (0.1%) | −252.1 | −249.0 | 26.47 |
| TP53 SRX19538268 | U2OS Bone | 347 / 9463 (3.7%) | 133 / 94630 (0.1%) | −247.6 | −244.4 | 26.09 |
| TP53 SRX19538276 | U2OS Bone | 346 / 9463 (3.7%) | 132 / 94630 (0.1%) | −247.2 | −244.0 | 26.21 |
| TP53 SRX19538280 | Osteoblasts Bone | 343 / 9463 (3.6%) | 146 / 94630 (0.2%) | −237.4 | −234.3 | 23.49 |
| TP53 SRX19538281 | Osteoblasts Bone | 352 / 9463 (3.7%) | 193 / 94630 (0.2%) | −224.5 | −221.4 | 18.24 |
| TP53 SRX19538273 | U2OS Bone | 310 / 9463 (3.3%) | 120 / 94630 (0.1%) | −220.5 | −217.4 | 25.83 |
| TP53 SRX19538267 | U2OS Bone | 311 / 9463 (3.3%) | 125 / 94630 (0.1%) | −218.8 | −215.8 | 24.88 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 319 / 9463 (3.4%) | 152 / 94630 (0.2%) | −213.2 | −210.1 | 20.99 |
| TP53 SRX19538269 | U2OS Bone | 375 / 9463 (4.0%) | 286 / 94630 (0.3%) | −210.0 | −207.0 | 13.11 |
| TP53 SRX19538275 | U2OS Bone | 310 / 9463 (3.3%) | 144 / 94630 (0.2%) | −208.8 | −205.8 | 21.53 |
| TP53 SRX19538270 | U2OS Bone | 358 / 9463 (3.8%) | 263 / 94630 (0.3%) | −203.7 | −200.7 | 13.61 |
| PBX4 SRX2731658 | PC-3 Prostate | 489 / 9463 (5.2%) | 14665 / 94630 (15.5%) | −202.0 | −199.0 | 0.33 |
| IRF3 SRX11453858 | Hep G2 Liver | 252 / 9463 (2.7%) | 66 / 94630 (0.1%) | −197.1 | −194.2 | 38.18 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 632 / 9463 (6.7%) | 1306 / 94630 (1.4%) | −187.8 | −184.9 | 4.84 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 448 / 9463 (4.7%) | 593 / 94630 (0.6%) | −186.9 | −183.9 | 7.55 |
| IRF3 SRX11453861 | Hep G2 Liver | 232 / 9463 (2.5%) | 58 / 94630 (0.1%) | −183.3 | −180.3 | 40.00 |
| TP53 SRX19538282 | Osteoblasts Bone | 304 / 9463 (3.2%) | 196 / 94630 (0.2%) | −182.4 | −179.5 | 15.51 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 802 / 9463 (8.5%) | 2172 / 94630 (2.3%) | −181.3 | −178.4 | 3.69 |
| TP53 SRX19538271 | U2OS Bone | 481 / 9463 (5.1%) | 740 / 94630 (0.8%) | −181.1 | −178.2 | 6.50 |
| BRD4 SRX736204 | 90-8TL Neural | 689 / 9463 (7.3%) | 1661 / 94630 (1.8%) | −176.4 | −173.5 | 4.15 |
| YAP1 SRX757325 | H2052 Lung | 346 / 9463 (3.7%) | 11490 / 94630 (12.1%) | −173.1 | −170.2 | 0.30 |
| ESR1 SRX4367193 | MCF-7 Breast | 487 / 9463 (5.1%) | 13302 / 94630 (14.1%) | −160.8 | −157.9 | 0.37 |
| FOS SRX150477 | MCF 10A Breast | 338 / 9463 (3.6%) | 10949 / 94630 (11.6%) | −160.0 | −157.1 | 0.31 |
| FOXA1 SRX4815198 | MCF-7 Breast | 502 / 9463 (5.3%) | 13489 / 94630 (14.3%) | −159.7 | −156.8 | 0.37 |
| YAP1 SRX757326 | H2052 Lung | 301 / 9463 (3.2%) | 10242 / 94630 (10.8%) | −156.7 | −153.9 | 0.29 |
| ESR1 SRX7624157 | MCF-7 Breast | 379 / 9463 (4.0%) | 11446 / 94630 (12.1%) | −154.9 | −152.1 | 0.33 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 409 / 9463 (4.3%) | 631 / 94630 (0.7%) | −153.4 | −150.6 | 6.48 |
| FOS SRX150478 | MCF 10A Breast | 366 / 9463 (3.9%) | 11187 / 94630 (11.8%) | −153.3 | −150.4 | 0.33 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 317 / 9463 (3.3%) | 10384 / 94630 (11.0%) | −152.8 | −150.0 | 0.31 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 391 / 9463 (4.1%) | 601 / 94630 (0.6%) | −147.0 | −144.2 | 6.51 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 767 / 9463 (8.1%) | 2368 / 94630 (2.5%) | −147.0 | −144.2 | 3.24 |
| AR SRX10820653 | LNCAP Prostate | 235 / 9463 (2.5%) | 137 / 94630 (0.1%) | −146.5 | −143.7 | 17.15 |
| KAT6A SRX20971022 | Fibroblasts Others | 196 / 9463 (2.1%) | 63 / 94630 (0.1%) | −146.3 | −143.5 | 31.11 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 862 / 9463 (9.1%) | 2929 / 94630 (3.1%) | −144.9 | −142.2 | 2.94 |
| FOXA1 SRX176862 | MCF-7 Breast | 180 / 9463 (1.9%) | 7681 / 94630 (8.1%) | −141.6 | −138.9 | 0.23 |
| ESR1 SRX371478 | MCF-7 Breast | 180 / 9463 (1.9%) | 7631 / 94630 (8.1%) | −140.1 | −137.3 | 0.24 |
| FOXA1 SRX4815197 | MCF-7 Breast | 382 / 9463 (4.0%) | 10967 / 94630 (11.6%) | −138.9 | −136.2 | 0.35 |
| TP53 SRX19538272 | U2OS Bone | 399 / 9463 (4.2%) | 691 / 94630 (0.7%) | −137.0 | −134.3 | 5.77 |
| GATA3 SRX190239 | MCF-7 Breast | 218 / 9463 (2.3%) | 8211 / 94630 (8.7%) | −136.7 | −134.0 | 0.27 |
| ESR1 SRX371469 | MCF-7 Breast | 138 / 9463 (1.5%) | 6741 / 94630 (7.1%) | −136.6 | −133.8 | 0.20 |
| ESR1 SRX20282961 | MCF-7 Breast | 184 / 9463 (1.9%) | 7555 / 94630 (8.0%) | −135.0 | −132.2 | 0.24 |
| FOXA1 SRX3931044 | MCF-7 Breast | 343 / 9463 (3.6%) | 10183 / 94630 (10.8%) | −133.7 | −131.0 | 0.34 |
| ESR1 SRX176860 | MCF-7 Breast | 253 / 9463 (2.7%) | 8713 / 94630 (9.2%) | −133.6 | −130.8 | 0.29 |
| ESR1 SRX7624156 | MCF-7 Breast | 244 / 9463 (2.6%) | 8542 / 94630 (9.0%) | −132.9 | −130.2 | 0.29 |
| FOXA1 SRX176863 | MCF-7 Breast | 173 / 9463 (1.8%) | 7276 / 94630 (7.7%) | −132.2 | −129.5 | 0.24 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 167 / 9463 (1.8%) | 7082 / 94630 (7.5%) | −129.4 | −126.7 | 0.24 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 193 / 9463 (2.0%) | 93 / 94630 (0.1%) | −128.5 | −125.8 | 20.75 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 171 / 9463 (1.8%) | 7104 / 94630 (7.5%) | −127.7 | −125.1 | 0.24 |
| FOXA1 SRX1161177 | MCF-7 Breast | 148 / 9463 (1.6%) | 6629 / 94630 (7.0%) | −126.2 | −123.5 | 0.22 |
| AR SRX10820651 | LNCAP Prostate | 238 / 9463 (2.5%) | 207 / 94630 (0.2%) | −125.3 | −122.6 | 11.50 |
| FOS SRX4192880 | MCF 10A Breast | 278 / 9463 (2.9%) | 8827 / 94630 (9.3%) | −124.1 | −121.4 | 0.31 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 591 / 9463 (6.2%) | 13501 / 94630 (14.3%) | −123.9 | −121.2 | 0.44 |
| TLE3 SRX4815191 | MCF-7 Breast | 138 / 9463 (1.5%) | 6355 / 94630 (6.7%) | −123.2 | −120.6 | 0.22 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 229 / 9463 (2.4%) | 7976 / 94630 (8.4%) | −123.1 | −120.4 | 0.29 |
| ESR1 SRX371479 | MCF-7 Breast | 135 / 9463 (1.4%) | 6281 / 94630 (6.6%) | −122.6 | −119.9 | 0.21 |
| ESR1 SRX194569 | MCF-7 Breast | 158 / 9463 (1.7%) | 6706 / 94630 (7.1%) | −122.4 | −119.8 | 0.24 |
| YAP1 SRX5718140 | 293 Kidney | 276 / 9463 (2.9%) | 8722 / 94630 (9.2%) | −121.9 | −119.3 | 0.32 |
| ESR1 SRX176861 | MCF-7 Breast | 273 / 9463 (2.9%) | 8671 / 94630 (9.2%) | −121.8 | −119.2 | 0.31 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 279 / 9463 (2.9%) | 8763 / 94630 (9.3%) | −121.8 | −119.2 | 0.32 |
| JUNB SRX8488088 | SUM 229PE Breast | 323 / 9463 (3.4%) | 9467 / 94630 (10.0%) | −121.7 | −119.1 | 0.34 |
| SMARCA2 SRX8119677 | MeT-5A Others | 261 / 9463 (2.8%) | 8465 / 94630 (8.9%) | −121.6 | −119.0 | 0.31 |
| ESR1 SRX371471 | ZR-75-1 Breast | 167 / 9463 (1.8%) | 6840 / 94630 (7.2%) | −121.4 | −118.8 | 0.24 |
| ESR1 SRX20282960 | MCF-7 Breast | 180 / 9463 (1.9%) | 7057 / 94630 (7.5%) | −120.7 | −118.1 | 0.26 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 203 / 9463 (2.1%) | 7454 / 94630 (7.9%) | −120.6 | −118.0 | 0.27 |
| ESR1 SRX371467 | MCF-7 Breast | 162 / 9463 (1.7%) | 6705 / 94630 (7.1%) | −119.8 | −117.3 | 0.24 |
| 5-mC SRX882970 | LNCAP Prostate | 1635 / 9463 (17.3%) | 8658 / 94630 (9.1%) | −119.7 | −117.2 | 1.89 |
| ESR1 SRX10365535 | MCF-7 Breast | 111 / 9463 (1.2%) | 5729 / 94630 (6.1%) | −119.6 | −117.1 | 0.19 |
| ESR1 SRX20282939 | MCF-7 Breast | 182 / 9463 (1.9%) | 7049 / 94630 (7.4%) | −119.4 | −116.9 | 0.26 |
| ESR1 SRX1531791 | MCF-7 Breast | 150 / 9463 (1.6%) | 6443 / 94630 (6.8%) | −118.5 | −116.0 | 0.23 |
| RAC1 SRX10365543 | MCF-7 Breast | 63 / 9463 (0.7%) | 4677 / 94630 (4.9%) | −118.3 | −115.8 | 0.13 |
| FOXA1 SRX1161176 | MCF-7 Breast | 147 / 9463 (1.6%) | 6376 / 94630 (6.7%) | −118.1 | −115.6 | 0.23 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 385 / 9463 (4.1%) | 10275 / 94630 (10.9%) | −117.4 | −114.9 | 0.37 |
| FOXA1 SRX371481 | MCF-7 Breast | 172 / 9463 (1.8%) | 6809 / 94630 (7.2%) | −117.4 | −114.9 | 0.25 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 601 / 9463 (6.4%) | 13389 / 94630 (14.1%) | −117.3 | −114.8 | 0.45 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 235 / 9463 (2.5%) | 7895 / 94630 (8.3%) | −117.3 | −114.8 | 0.30 |
| 5-mC SRX882968 | LNCAP Prostate | 1609 / 9463 (17.0%) | 8531 / 94630 (9.0%) | −117.2 | −114.7 | 1.89 |
| CEBPB SRX150632 | HeLa Uterus | 395 / 9463 (4.2%) | 10399 / 94630 (11.0%) | −116.6 | −114.1 | 0.38 |
| CDK9 SRX7366783 | MCF-7 Breast | 184 / 9463 (1.9%) | 104 / 94630 (0.1%) | −116.0 | −113.5 | 17.69 |
| AR SRX1067071 | LHSAR Prostate | 338 / 9463 (3.6%) | 9497 / 94630 (10.0%) | −115.8 | −113.2 | 0.36 |
| ESR1 SRX20282972 | MCF-7 Breast | 183 / 9463 (1.9%) | 6949 / 94630 (7.3%) | −115.6 | −113.1 | 0.26 |
| NR2F2 SRX190293 | MCF-7 Breast | 161 / 9463 (1.7%) | 6554 / 94630 (6.9%) | −115.5 | −113.0 | 0.25 |
| ESR1 SRX20282973 | MCF-7 Breast | 199 / 9463 (2.1%) | 7222 / 94630 (7.6%) | −115.3 | −112.8 | 0.28 |
| ESR1 SRX10365536 | MCF-7 Breast | 65 / 9463 (0.7%) | 4629 / 94630 (4.9%) | −114.7 | −112.3 | 0.14 |
| ESR1 SRX4367192 | MCF-7 Breast | 365 / 9463 (3.9%) | 9873 / 94630 (10.4%) | −114.7 | −112.2 | 0.37 |
| NFYB SRX16608147 | HeLa Uterus | 194 / 9463 (2.1%) | 131 / 94630 (0.1%) | −114.3 | −111.8 | 14.81 |
| FOXA1 SRX371482 | MCF-7 Breast | 251 / 9463 (2.7%) | 8057 / 94630 (8.5%) | −114.1 | −111.6 | 0.31 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 429 / 9463 (4.5%) | 10805 / 94630 (11.4%) | −113.9 | −111.4 | 0.40 |
| AR SRX1067070 | LHSAR Prostate | 432 / 9463 (4.6%) | 10832 / 94630 (11.4%) | −113.4 | −110.9 | 0.40 |
| AGO2 SRX4708039 | Hep G2 Liver | 1010 / 9463 (10.7%) | 4366 / 94630 (4.6%) | −113.4 | −110.9 | 2.31 |
| ESR1 SRX194572 | MCF-7 Breast | 91 / 9463 (1.0%) | 5144 / 94630 (5.4%) | −113.3 | −110.9 | 0.18 |
| CDK9 SRX7366781 | MCF-7 Breast | 174 / 9463 (1.8%) | 90 / 94630 (0.1%) | −113.2 | −110.7 | 19.33 |
| ESR1 SRX371470 | ZR-75-1 Breast | 144 / 9463 (1.5%) | 6173 / 94630 (6.5%) | −113.1 | −110.6 | 0.23 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 119 / 9463 (1.3%) | 5691 / 94630 (6.0%) | −112.9 | −110.5 | 0.21 |
| FOXA1 SRX371483 | MCF-7 Breast | 191 / 9463 (2.0%) | 7005 / 94630 (7.4%) | −112.8 | −110.4 | 0.27 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 293 / 9463 (3.1%) | 436 / 94630 (0.5%) | −112.6 | −110.2 | 6.72 |
| VGLL1 SRX24602130 | BT-20 Breast | 165 / 9463 (1.7%) | 6533 / 94630 (6.9%) | −112.5 | −110.0 | 0.25 |
| FOS SRX150517 | MCF 10A Breast | 304 / 9463 (3.2%) | 8846 / 94630 (9.3%) | −112.3 | −109.8 | 0.34 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 222 / 9463 (2.3%) | 7512 / 94630 (7.9%) | −112.1 | −109.6 | 0.30 |
| FOXA1 SRX1161173 | MCF-7 Breast | 125 / 9463 (1.3%) | 5751 / 94630 (6.1%) | −111.0 | −108.5 | 0.22 |
| ARID1A SRX5089376 | MCF-7 Breast | 135 / 9463 (1.4%) | 5939 / 94630 (6.3%) | −110.9 | −108.4 | 0.23 |
| STAT5B SRX831881 | CD8+ T cells Blood | 177 / 9463 (1.9%) | 103 / 94630 (0.1%) | −110.5 | −108.0 | 17.18 |
| ESR1 SRX371468 | MCF-7 Breast | 95 / 9463 (1.0%) | 5142 / 94630 (5.4%) | −110.2 | −107.8 | 0.18 |
| ESR1 SRX20282954 | MCF-7 Breast | 187 / 9463 (2.0%) | 6846 / 94630 (7.2%) | −110.0 | −107.6 | 0.27 |
| GATA3 SRX5057632 | MCF-7 Breast | 94 / 9463 (1.0%) | 5116 / 94630 (5.4%) | −110.0 | −107.6 | 0.18 |
| GATA3 SRX176864 | MCF-7 Breast | 117 / 9463 (1.2%) | 5522 / 94630 (5.8%) | −108.4 | −106.0 | 0.21 |
| STAT3 SRX2020842 | HCC70 Breast | 316 / 9463 (3.3%) | 8905 / 94630 (9.4%) | −108.4 | −106.0 | 0.35 |
| ESR1 SRX371476 | MCF-7 Breast | 117 / 9463 (1.2%) | 5510 / 94630 (5.8%) | −108.0 | −105.5 | 0.21 |
| RAC1 SRX10365541 | MCF-7 Breast | 73 / 9463 (0.8%) | 4614 / 94630 (4.9%) | −107.7 | −105.3 | 0.16 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 297 / 9463 (3.1%) | 8579 / 94630 (9.1%) | −107.7 | −105.3 | 0.35 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 321 / 9463 (3.4%) | 572 / 94630 (0.6%) | −107.6 | −105.2 | 5.61 |
| ESR1 SRX2881000 | MCF-7 Breast | 141 / 9463 (1.5%) | 5936 / 94630 (6.3%) | −107.0 | −104.6 | 0.24 |
| FOXA1 SRX1161175 | MCF-7 Breast | 120 / 9463 (1.3%) | 5535 / 94630 (5.8%) | −106.9 | −104.5 | 0.22 |
| ARID5B SRX3230377 | Hep G2 Liver | 461 / 9463 (4.9%) | 11008 / 94630 (11.6%) | −106.8 | −104.4 | 0.42 |
| Epitope tags SRX5877912 | U2OS Bone | 1104 / 9463 (11.7%) | 19497 / 94630 (20.6%) | −106.6 | −104.2 | 0.57 |
| ESR1 SRX20282940 | MCF-7 Breast | 189 / 9463 (2.0%) | 6771 / 94630 (7.2%) | −106.6 | −104.2 | 0.28 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 228 / 9463 (2.4%) | 7418 / 94630 (7.8%) | −106.2 | −103.8 | 0.31 |
| RELA SRX2207673 | HUVEC Cardiovascular | 694 / 9463 (7.3%) | 14212 / 94630 (15.0%) | −106.1 | −103.7 | 0.49 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 371 / 9463 (3.9%) | 797 / 94630 (0.8%) | −105.6 | −103.2 | 4.65 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 286 / 9463 (3.0%) | 452 / 94630 (0.5%) | −105.2 | −102.9 | 6.33 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 602 / 9463 (6.4%) | 12925 / 94630 (13.7%) | −105.1 | −102.8 | 0.47 |
| ESR1 SRX20282955 | MCF-7 Breast | 186 / 9463 (2.0%) | 6675 / 94630 (7.1%) | −105.1 | −102.7 | 0.28 |
| ARID1A SRX5089379 | MCF-7 Breast | 168 / 9463 (1.8%) | 6333 / 94630 (6.7%) | −104.2 | −101.9 | 0.27 |
| ESR1 SRX330067 | MCF-7 Breast | 152 / 9463 (1.6%) | 6044 / 94630 (6.4%) | −104.0 | −101.7 | 0.25 |
| ESR1 SRX5323873 | MCF-7 Breast | 215 / 9463 (2.3%) | 7130 / 94630 (7.5%) | −104.0 | −101.6 | 0.30 |
| FOXA1 SRX3923514 | MCF-7 Breast | 174 / 9463 (1.8%) | 6426 / 94630 (6.8%) | −103.8 | −101.4 | 0.27 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 173 / 9463 (1.8%) | 6392 / 94630 (6.8%) | −103.2 | −100.9 | 0.27 |
| ESR1 SRX10365558 | MCF-7 Breast | 105 / 9463 (1.1%) | 5114 / 94630 (5.4%) | −102.4 | −100.1 | 0.21 |
| FOXA1 SRX100454 | T-47D Breast | 237 / 9463 (2.5%) | 7438 / 94630 (7.9%) | −102.3 | −100.0 | 0.32 |
| ESR1 SRX2881002 | MCF-7 Breast | 164 / 9463 (1.7%) | 6196 / 94630 (6.5%) | −102.0 | −99.7 | 0.26 |
| ESR1 SRX20282971 | MCF-7 Breast | 174 / 9463 (1.8%) | 6353 / 94630 (6.7%) | −101.4 | −99.1 | 0.27 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 164 / 9463 (1.7%) | 6172 / 94630 (6.5%) | −101.3 | −99.0 | 0.27 |
| 5-mC SRX882965 | LNCAP Prostate | 1312 / 9463 (13.9%) | 6755 / 94630 (7.1%) | −101.1 | −98.7 | 1.94 |
| FOS SRX150476 | MCF 10A Breast | 328 / 9463 (3.5%) | 8828 / 94630 (9.3%) | −101.0 | −98.7 | 0.37 |
| TLE3 SRX4815192 | MCF-7 Breast | 156 / 9463 (1.6%) | 6018 / 94630 (6.4%) | −101.0 | −98.7 | 0.26 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 69 / 9463 (0.7%) | 4334 / 94630 (4.6%) | −100.8 | −98.5 | 0.16 |
| BMI1 SRX644729 | 293 Kidney | 164 / 9463 (1.7%) | 100 / 94630 (0.1%) | −100.6 | −98.3 | 16.40 |
| ESR1 SRX10365532 | MCF-7 Breast | 82 / 9463 (0.9%) | 4594 / 94630 (4.9%) | −100.3 | −98.0 | 0.18 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 175 / 9463 (1.8%) | 6330 / 94630 (6.7%) | −100.2 | −97.9 | 0.28 |
| FOXA1 SRX371480 | MCF-7 Breast | 114 / 9463 (1.2%) | 5222 / 94630 (5.5%) | −100.2 | −97.9 | 0.22 |
| RELA SRX2207672 | HUVEC Cardiovascular | 757 / 9463 (8.0%) | 14789 / 94630 (15.6%) | −100.0 | −97.7 | 0.51 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 197 / 9463 (2.1%) | 6691 / 94630 (7.1%) | −99.7 | −97.4 | 0.29 |
| EP300 SRX1012648 | MCF-7 Breast | 67 / 9463 (0.7%) | 4258 / 94630 (4.5%) | −99.7 | −97.4 | 0.16 |
| FOXA1 SRX11222441 | MCF-7 Breast | 128 / 9463 (1.4%) | 5468 / 94630 (5.8%) | −99.6 | −97.3 | 0.23 |
| GATA3 SRX190194 | SK-N-SH Neural | 466 / 9463 (4.9%) | 10806 / 94630 (11.4%) | −99.5 | −97.2 | 0.43 |
| ESR1 SRX20282946 | MCF-7 Breast | 98 / 9463 (1.0%) | 4889 / 94630 (5.2%) | −99.4 | −97.1 | 0.20 |
| ESR1 SRX330069 | MCF-7 Breast | 98 / 9463 (1.0%) | 4874 / 94630 (5.2%) | −98.8 | −96.5 | 0.20 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 161 / 9463 (1.7%) | 6039 / 94630 (6.4%) | −98.8 | −96.5 | 0.27 |
| FOXA1 SRX1161174 | MCF-7 Breast | 189 / 9463 (2.0%) | 6524 / 94630 (6.9%) | −98.7 | −96.4 | 0.29 |
| ESR1 SRX5323871 | MCF-7 Breast | 195 / 9463 (2.1%) | 6621 / 94630 (7.0%) | −98.6 | −96.4 | 0.29 |
| ESR1 SRX4451213 | MCF-7 Breast | 183 / 9463 (1.9%) | 6414 / 94630 (6.8%) | −98.4 | −96.2 | 0.29 |
| ESR1 SRX3110725 | MCF-7 Breast | 157 / 9463 (1.7%) | 5957 / 94630 (6.3%) | −98.4 | −96.1 | 0.26 |
| ESR1 SRX371477 | MCF-7 Breast | 75 / 9463 (0.8%) | 4391 / 94630 (4.6%) | −98.2 | −96.0 | 0.17 |
| ESR1 SRX371475 | BT-474 Breast | 76 / 9463 (0.8%) | 4403 / 94630 (4.7%) | −97.9 | −95.7 | 0.17 |
| Epitope tags SRX10549776 | K-562 Blood | 760 / 9463 (8.0%) | 3035 / 94630 (3.2%) | −97.8 | −95.5 | 2.50 |
| SS18 SRX3468047 | Fibroblasts Others | 496 / 9463 (5.2%) | 11151 / 94630 (11.8%) | −97.6 | −95.3 | 0.44 |
| ESR1 SRX20282938 | MCF-7 Breast | 142 / 9463 (1.5%) | 5662 / 94630 (6.0%) | −97.4 | −95.2 | 0.25 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 177 / 9463 (1.9%) | 6270 / 94630 (6.6%) | −97.2 | −94.9 | 0.28 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 379 / 9463 (4.0%) | 9446 / 94630 (10.0%) | −96.9 | −94.6 | 0.40 |
| Epitope tags SRX5877914 | U2OS Bone | 1132 / 9463 (12.0%) | 19380 / 94630 (20.5%) | −96.7 | −94.5 | 0.58 |
| FOXA1 SRX11222437 | MCF-7 Breast | 123 / 9463 (1.3%) | 5284 / 94630 (5.6%) | −96.5 | −94.2 | 0.23 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 481 / 9463 (5.1%) | 10903 / 94630 (11.5%) | −96.5 | −94.2 | 0.44 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 332 / 9463 (3.5%) | 8727 / 94630 (9.2%) | −96.4 | −94.2 | 0.38 |
| FOXA1 SRX1787653 | MCF-7 Breast | 145 / 9463 (1.5%) | 5682 / 94630 (6.0%) | −96.4 | −94.1 | 0.26 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 138 / 9463 (1.5%) | 5544 / 94630 (5.9%) | −96.1 | −93.8 | 0.25 |
| ESR1 SRX20282953 | MCF-7 Breast | 145 / 9463 (1.5%) | 5662 / 94630 (6.0%) | −95.8 | −93.5 | 0.26 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 170 / 9463 (1.8%) | 6102 / 94630 (6.4%) | −95.7 | −93.5 | 0.28 |
| ESR1 SRX1012629 | MCF-7 Breast | 104 / 9463 (1.1%) | 4895 / 94630 (5.2%) | −95.6 | −93.3 | 0.21 |
| ESR1 SRX330070 | MCF-7 Breast | 82 / 9463 (0.9%) | 4458 / 94630 (4.7%) | −95.5 | −93.3 | 0.18 |
| ESR1 SRX8537722 | MCF-7 Breast | 169 / 9463 (1.8%) | 6073 / 94630 (6.4%) | −95.3 | −93.1 | 0.28 |
| ESR1 SRX5323872 | MCF-7 Breast | 184 / 9463 (1.9%) | 6319 / 94630 (6.7%) | −95.1 | −92.9 | 0.29 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 172 / 9463 (1.8%) | 6117 / 94630 (6.5%) | −95.1 | −92.8 | 0.28 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 168 / 9463 (1.8%) | 6038 / 94630 (6.4%) | −94.8 | −92.6 | 0.28 |
| EP300 SRX150579 | HeLa Uterus | 113 / 9463 (1.2%) | 5042 / 94630 (5.3%) | −94.7 | −92.5 | 0.22 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 590 / 9463 (6.2%) | 12321 / 94630 (13.0%) | −94.3 | −92.1 | 0.48 |
| FOXA2 SRX3230382 | Hep G2 Liver | 263 / 9463 (2.8%) | 7582 / 94630 (8.0%) | −94.2 | −92.0 | 0.35 |
| ESR1 SRX2912055 | MCF-7 Breast | 55 / 9463 (0.6%) | 3841 / 94630 (4.1%) | −94.0 | −91.8 | 0.14 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 172 / 9463 (1.8%) | 6073 / 94630 (6.4%) | −93.8 | −91.6 | 0.28 |
| ESR1 SRX2943591 | MCF-7 Breast | 123 / 9463 (1.3%) | 5202 / 94630 (5.5%) | −93.8 | −91.6 | 0.24 |
| TEAD1 SRX3401272 | MCF-7 Breast | 133 / 9463 (1.4%) | 5383 / 94630 (5.7%) | −93.7 | −91.5 | 0.25 |
| EP300 SRX2194266 | SUM 159PT Breast | 342 / 9463 (3.6%) | 8756 / 94630 (9.3%) | −93.2 | −91.0 | 0.39 |
| ESR1 SRX3123829 | MCF-7 Breast | 97 / 9463 (1.0%) | 4690 / 94630 (5.0%) | −93.2 | −90.9 | 0.21 |
| ESR1 SRX371474 | BT-474 Breast | 74 / 9463 (0.8%) | 4223 / 94630 (4.5%) | −93.1 | −90.9 | 0.18 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 172 / 9463 (1.8%) | 6047 / 94630 (6.4%) | −92.9 | −90.7 | 0.28 |
| GATA3 SRX5457550 | MCF-7 Breast | 221 / 9463 (2.3%) | 6862 / 94630 (7.3%) | −92.8 | −90.6 | 0.32 |
| FOXA1 SRX028634 | MCF-7 Breast | 81 / 9463 (0.9%) | 4356 / 94630 (4.6%) | −92.7 | −90.5 | 0.19 |
| FOXA1 SRX3931043 | MCF-7 Breast | 194 / 9463 (2.1%) | 6410 / 94630 (6.8%) | −92.7 | −90.4 | 0.30 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 472 / 9463 (5.0%) | 10618 / 94630 (11.2%) | −92.6 | −90.4 | 0.44 |
| FOS SRX4192879 | MCF 10A Breast | 229 / 9463 (2.4%) | 6983 / 94630 (7.4%) | −92.6 | −90.4 | 0.33 |
| FOXA1 SRX100506 | Hep G2 Liver | 264 / 9463 (2.8%) | 7524 / 94630 (8.0%) | −92.1 | −89.9 | 0.35 |
| PGR SRX1012655 | MCF-7 Breast | 110 / 9463 (1.2%) | 4906 / 94630 (5.2%) | −92.1 | −89.9 | 0.22 |
| ESR1 SRX11120903 | MCF-7 Breast | 163 / 9463 (1.7%) | 5866 / 94630 (6.2%) | −92.1 | −89.9 | 0.28 |
| FOXA1 SRX11222442 | MCF-7 Breast | 119 / 9463 (1.3%) | 5073 / 94630 (5.4%) | −92.0 | −89.8 | 0.23 |
| ESR1 SRX1531796 | MCF-7 Breast | 90 / 9463 (1.0%) | 4516 / 94630 (4.8%) | −91.9 | −89.7 | 0.20 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 575 / 9463 (6.1%) | 12014 / 94630 (12.7%) | −91.8 | −89.6 | 0.48 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 714 / 9463 (7.5%) | 13867 / 94630 (14.7%) | −91.8 | −89.6 | 0.51 |
| WWTR1 SRX10119367 | MCF 10A Breast | 227 / 9463 (2.4%) | 6918 / 94630 (7.3%) | −91.6 | −89.5 | 0.33 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 176 / 9463 (1.9%) | 6070 / 94630 (6.4%) | −91.4 | −89.3 | 0.29 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 204 / 9463 (2.2%) | 6537 / 94630 (6.9%) | −91.4 | −89.3 | 0.31 |
| FOXA1 SRX3931054 | MCF-7 Breast | 178 / 9463 (1.9%) | 6095 / 94630 (6.4%) | −91.3 | −89.1 | 0.29 |
| SOX13 SRX2636248 | Hep G2 Liver | 271 / 9463 (2.9%) | 7602 / 94630 (8.0%) | −91.2 | −89.0 | 0.36 |
| FOXA2 SRX100448 | Hep G2 Liver | 216 / 9463 (2.3%) | 6723 / 94630 (7.1%) | −91.1 | −88.9 | 0.32 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 463 / 9463 (4.9%) | 10431 / 94630 (11.0%) | −91.0 | −88.9 | 0.44 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 180 / 9463 (1.9%) | 6124 / 94630 (6.5%) | −91.0 | −88.9 | 0.29 |
| ESR1 SRX1012632 | MCF-7 Breast | 82 / 9463 (0.9%) | 4326 / 94630 (4.6%) | −91.0 | −88.8 | 0.19 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 133 / 9463 (1.4%) | 5288 / 94630 (5.6%) | −90.7 | −88.5 | 0.25 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 182 / 9463 (1.9%) | 6145 / 94630 (6.5%) | −90.7 | −88.5 | 0.30 |
| TEAD3 SRX2636153 | Hep G2 Liver | 487 / 9463 (5.1%) | 10757 / 94630 (11.4%) | −90.7 | −88.5 | 0.45 |
| ESR1 SRX4451212 | MCF-7 Breast | 179 / 9463 (1.9%) | 6092 / 94630 (6.4%) | −90.6 | −88.5 | 0.29 |
| ESR1 SRX20282959 | MCF-7 Breast | 66 / 9463 (0.7%) | 3986 / 94630 (4.2%) | −90.6 | −88.5 | 0.17 |
| ESR1 SRX2513517 | MCF-7 Breast | 125 / 9463 (1.3%) | 5140 / 94630 (5.4%) | −90.6 | −88.5 | 0.24 |
| ESR1 SRX2513520 | MCF-7 Breast | 113 / 9463 (1.2%) | 4917 / 94630 (5.2%) | −90.6 | −88.5 | 0.23 |
| JUNB SRX8488073 | SUM 229PE Breast | 377 / 9463 (4.0%) | 9179 / 94630 (9.7%) | −90.6 | −88.4 | 0.41 |
| CEBPB SRX190345 | MCF-7 Breast | 140 / 9463 (1.5%) | 5406 / 94630 (5.7%) | −90.4 | −88.3 | 0.26 |
| FOXA1 SRX5323843 | MCF-7 Breast | 88 / 9463 (0.9%) | 4428 / 94630 (4.7%) | −90.2 | −88.1 | 0.20 |
| ESR1 SRX10365533 | MCF-7 Breast | 79 / 9463 (0.8%) | 4247 / 94630 (4.5%) | −90.2 | −88.1 | 0.19 |
| ESR1 SRX1469949 | MCF-7 Breast | 102 / 9463 (1.1%) | 4699 / 94630 (5.0%) | −90.2 | −88.1 | 0.22 |
| FOXA1 SRX1787655 | MCF-7 Breast | 84 / 9463 (0.9%) | 4344 / 94630 (4.6%) | −90.1 | −87.9 | 0.19 |
| SSRP1 SRX3436567 | HT-1080 Bone | 231 / 9463 (2.4%) | 337 / 94630 (0.4%) | −90.1 | −87.9 | 6.85 |
| FOXA1 SRX3931055 | MCF-7 Breast | 160 / 9463 (1.7%) | 5744 / 94630 (6.1%) | −89.9 | −87.7 | 0.28 |
| Epitope tags SRX5877913 | U2OS Bone | 1131 / 9463 (12.0%) | 19034 / 94630 (20.1%) | −89.8 | −87.7 | 0.59 |
| SMARCA4 SRX5212362 | Mel270 Others | 349 / 9463 (3.7%) | 8737 / 94630 (9.2%) | −89.8 | −87.7 | 0.40 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 84 / 9463 (0.9%) | 4333 / 94630 (4.6%) | −89.8 | −87.6 | 0.19 |
| FOXA1 SRX028635 | MCF-7 Breast | 87 / 9463 (0.9%) | 4388 / 94630 (4.6%) | −89.6 | −87.5 | 0.20 |
| CEBPA SRX2630241 | Hep G2 Liver | 243 / 9463 (2.6%) | 7097 / 94630 (7.5%) | −89.3 | −87.2 | 0.34 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 186 / 9463 (2.0%) | 6168 / 94630 (6.5%) | −89.3 | −87.2 | 0.30 |
| WWTR1 SRX10119378 | MCF 10A Breast | 209 / 9463 (2.2%) | 6544 / 94630 (6.9%) | −89.2 | −87.1 | 0.32 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 437 / 9463 (4.6%) | 9985 / 94630 (10.6%) | −89.0 | −86.9 | 0.44 |
| PROX1 SRX3230397 | Hep G2 Liver | 133 / 9463 (1.4%) | 5233 / 94630 (5.5%) | −88.9 | −86.8 | 0.25 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 176 / 9463 (1.9%) | 5984 / 94630 (6.3%) | −88.9 | −86.8 | 0.29 |
| FOXA1 SRX5203303 | MCF-7 Breast | 54 / 9463 (0.6%) | 3677 / 94630 (3.9%) | −88.8 | −86.7 | 0.15 |
| SMARCA4 SRX5212366 | Mel270 Others | 272 / 9463 (2.9%) | 7527 / 94630 (8.0%) | −88.7 | −86.5 | 0.36 |
| FOXA1 SRX11222438 | MCF-7 Breast | 93 / 9463 (1.0%) | 4471 / 94630 (4.7%) | −88.5 | −86.4 | 0.21 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 539 / 9463 (5.7%) | 11385 / 94630 (12.0%) | −88.5 | −86.3 | 0.47 |
| HMG20A SRX2630163 | Hep G2 Liver | 103 / 9463 (1.1%) | 4665 / 94630 (4.9%) | −88.4 | −86.3 | 0.22 |
| ARID5B SRX10475138 | Hep G2 Liver | 334 / 9463 (3.5%) | 8461 / 94630 (8.9%) | −88.3 | −86.2 | 0.39 |
| ESR1 SRX8537723 | MCF-7 Breast | 154 / 9463 (1.6%) | 5586 / 94630 (5.9%) | −88.3 | −86.2 | 0.28 |
| JUN SRX17561461 | LPS141 Adipocyte | 297 / 9463 (3.1%) | 7898 / 94630 (8.3%) | −88.2 | −86.1 | 0.38 |
| EP300 SRX1012643 | MCF-7 Breast | 56 / 9463 (0.6%) | 3700 / 94630 (3.9%) | −88.1 | −86.0 | 0.15 |
| EP300 SRX1012644 | MCF-7 Breast | 76 / 9463 (0.8%) | 4123 / 94630 (4.4%) | −88.1 | −86.0 | 0.18 |
| FOXA1 SRX3923516 | MCF-7 Breast | 138 / 9463 (1.5%) | 5288 / 94630 (5.6%) | −87.7 | −85.6 | 0.26 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 158 / 9463 (1.7%) | 5637 / 94630 (6.0%) | −87.7 | −85.6 | 0.28 |
| NR3C1 SRX17639412 | A549 Lung | 227 / 9463 (2.4%) | 6782 / 94630 (7.2%) | −87.6 | −85.5 | 0.33 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 136 / 9463 (1.4%) | 5246 / 94630 (5.5%) | −87.6 | −85.5 | 0.26 |
| ESR1 SRX5534831 | MCF-7 Breast | 146 / 9463 (1.5%) | 5410 / 94630 (5.7%) | −87.2 | −85.1 | 0.27 |
| EP300 SRX176885 | MCF-7 Breast | 96 / 9463 (1.0%) | 4489 / 94630 (4.7%) | −87.1 | −85.0 | 0.21 |
| ESR1 SRX330068 | MCF-7 Breast | 83 / 9463 (0.9%) | 4230 / 94630 (4.5%) | −86.9 | −84.8 | 0.20 |
| ESR1 SRX792933 | LY2 Breast | 157 / 9463 (1.7%) | 5587 / 94630 (5.9%) | −86.7 | −84.6 | 0.28 |
| FOXA1 SRX3923518 | MCF-7 Breast | 130 / 9463 (1.4%) | 5108 / 94630 (5.4%) | −86.6 | −84.5 | 0.25 |
| FOXA1 SRX1787652 | MCF-7 Breast | 115 / 9463 (1.2%) | 4831 / 94630 (5.1%) | −86.5 | −84.5 | 0.24 |
| ESR1 SRX2943589 | MCF-7 Breast | 91 / 9463 (1.0%) | 4375 / 94630 (4.6%) | −86.5 | −84.4 | 0.21 |
| ESR1 SRX5323878 | MCF-7 Breast | 197 / 9463 (2.1%) | 6258 / 94630 (6.6%) | −86.5 | −84.4 | 0.31 |
| FOXA1 SRX1787651 | MCF-7 Breast | 106 / 9463 (1.1%) | 4664 / 94630 (4.9%) | −86.5 | −84.4 | 0.23 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 139 / 9463 (1.5%) | 82 / 94630 (0.1%) | −86.4 | −84.4 | 16.95 |
| NR3C1 SRX8520802 | HCC1187 Breast | 138 / 9463 (1.5%) | 5245 / 94630 (5.5%) | −86.4 | −84.3 | 0.26 |
| AR SRX9109110 | MDA-MB-453 Breast | 388 / 9463 (4.1%) | 9174 / 94630 (9.7%) | −86.3 | −84.2 | 0.42 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 347 / 9463 (3.7%) | 852 / 94630 (0.9%) | −86.3 | −84.2 | 4.07 |
| FOXA1 SRX3923515 | MCF-7 Breast | 103 / 9463 (1.1%) | 4603 / 94630 (4.9%) | −86.3 | −84.2 | 0.22 |
| ARID5B SRX10475139 | Hep G2 Liver | 222 / 9463 (2.3%) | 6651 / 94630 (7.0%) | −86.2 | −84.1 | 0.33 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 168 / 9463 (1.8%) | 5761 / 94630 (6.1%) | −86.1 | −84.1 | 0.29 |
| FOXA1 SRX3923517 | MCF-7 Breast | 136 / 9463 (1.4%) | 5198 / 94630 (5.5%) | −86.1 | −84.0 | 0.26 |
| FOXA1 SRX1961157 | T-47D Breast | 216 / 9463 (2.3%) | 6548 / 94630 (6.9%) | −86.0 | −83.9 | 0.33 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 126 / 9463 (1.3%) | 5014 / 94630 (5.3%) | −85.9 | −83.9 | 0.25 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 162 / 9463 (1.7%) | 5644 / 94630 (6.0%) | −85.8 | −83.7 | 0.29 |
| ESR1 SRX2513521 | MCF-7 Breast | 86 / 9463 (0.9%) | 4248 / 94630 (4.5%) | −85.5 | −83.4 | 0.20 |
| GATA2 SRX16314543 | Trophoblast stem cells Placenta | 185 / 9463 (2.0%) | 6013 / 94630 (6.4%) | −85.2 | −83.2 | 0.31 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 148 / 9463 (1.6%) | 5383 / 94630 (5.7%) | −85.2 | −83.1 | 0.27 |
| ESR1 SRX3110723 | MCF-7 Breast | 100 / 9463 (1.1%) | 4511 / 94630 (4.8%) | −85.2 | −83.1 | 0.22 |
| GATA3 SRX6712581 | MCF-7 Breast | 161 / 9463 (1.7%) | 5607 / 94630 (5.9%) | −85.1 | −83.0 | 0.29 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 603 / 9463 (6.4%) | 12106 / 94630 (12.8%) | −85.1 | −83.0 | 0.50 |
| TCF12 SRX190356 | SK-N-SH Neural | 573 / 9463 (6.1%) | 11700 / 94630 (12.4%) | −85.0 | −83.0 | 0.49 |
| FOXL2 SRX6957431 | KGN Gonad | 477 / 9463 (5.0%) | 10384 / 94630 (11.0%) | −85.0 | −82.9 | 0.46 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 134 / 9463 (1.4%) | 75 / 94630 (0.1%) | −85.0 | −82.9 | 17.87 |
| SP1 SRX5457499 | Liver Liver | 364 / 9463 (3.8%) | 8773 / 94630 (9.3%) | −84.9 | −82.9 | 0.41 |
| FOXA1 SRX15430999 | T-47D Breast | 225 / 9463 (2.4%) | 6657 / 94630 (7.0%) | −84.9 | −82.9 | 0.34 |
| FOXA1 SRX1961158 | T-47D Breast | 199 / 9463 (2.1%) | 6232 / 94630 (6.6%) | −84.8 | −82.8 | 0.32 |
| ARID1A SRX5089385 | MCF-7 Breast | 143 / 9463 (1.5%) | 5278 / 94630 (5.6%) | −84.7 | −82.7 | 0.27 |
| JUNB SRX8488089 | SUM 229PE Breast | 207 / 9463 (2.2%) | 6358 / 94630 (6.7%) | −84.7 | −82.6 | 0.33 |
| GATA3 SRX100559 | T-47D Breast | 229 / 9463 (2.4%) | 6698 / 94630 (7.1%) | −84.2 | −82.2 | 0.34 |
| AR SRX9469988 | LAPC-4 Prostate | 280 / 9463 (3.0%) | 7485 / 94630 (7.9%) | −84.1 | −82.0 | 0.37 |
| JUN SRX4192884 | MCF 10A Breast | 170 / 9463 (1.8%) | 5722 / 94630 (6.0%) | −83.9 | −81.9 | 0.30 |
| GATAD2A SRX2636506 | Hep G2 Liver | 262 / 9463 (2.8%) | 7201 / 94630 (7.6%) | −83.8 | −81.8 | 0.36 |
| FOXA1 SRX1161203 | T-47D Breast | 144 / 9463 (1.5%) | 5270 / 94630 (5.6%) | −83.8 | −81.7 | 0.27 |
| ARID1A SRX5089388 | MCF-7 Breast | 94 / 9463 (1.0%) | 4355 / 94630 (4.6%) | −83.8 | −81.7 | 0.22 |
| AR SRX9109113 | MDA-MB-453 Breast | 403 / 9463 (4.3%) | 9285 / 94630 (9.8%) | −83.6 | −81.6 | 0.43 |
| ESR1 SRX1995229 | MCF-7 Breast | 205 / 9463 (2.2%) | 6283 / 94630 (6.6%) | −83.5 | −81.4 | 0.33 |
| FOXA1 SRX5323845 | MCF-7 Breast | 62 / 9463 (0.7%) | 3700 / 94630 (3.9%) | −83.4 | −81.4 | 0.17 |
| FOXA1 SRX3923519 | MCF-7 Breast | 119 / 9463 (1.3%) | 4807 / 94630 (5.1%) | −83.3 | −81.2 | 0.25 |
| ESR1 SRX5323877 | MCF-7 Breast | 155 / 9463 (1.6%) | 5442 / 94630 (5.8%) | −83.2 | −81.1 | 0.28 |
| AR SRX1067067 | LHSAR Prostate | 359 / 9463 (3.8%) | 8634 / 94630 (9.1%) | −83.2 | −81.1 | 0.42 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 54 / 9463 (0.6%) | 3515 / 94630 (3.7%) | −83.0 | −81.0 | 0.15 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 274 / 9463 (2.9%) | 7357 / 94630 (7.8%) | −83.0 | −80.9 | 0.37 |
| FOXA2 SRX10475773 | Hep G2 Liver | 249 / 9463 (2.6%) | 6970 / 94630 (7.4%) | −83.0 | −80.9 | 0.36 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 137 / 9463 (1.4%) | 87 / 94630 (0.1%) | −82.9 | −80.8 | 15.75 |
| VGLL1 SRX18013277 | FULVR Breast | 79 / 9463 (0.8%) | 4029 / 94630 (4.3%) | −82.7 | −80.7 | 0.20 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 532 / 9463 (5.6%) | 11043 / 94630 (11.7%) | −82.6 | −80.6 | 0.48 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 730 / 9463 (7.7%) | 3121 / 94630 (3.3%) | −82.5 | −80.5 | 2.34 |
| ESR1 SRX1469951 | MCF-7 Breast | 100 / 9463 (1.1%) | 4431 / 94630 (4.7%) | −82.4 | −80.4 | 0.23 |
| ESR1 SRX2881001 | MCF-7 Breast | 108 / 9463 (1.1%) | 4579 / 94630 (4.8%) | −82.4 | −80.4 | 0.24 |
| ARID1A SRX5089391 | MCF-7 Breast | 105 / 9463 (1.1%) | 4519 / 94630 (4.8%) | −82.3 | −80.3 | 0.23 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 161 / 9463 (1.7%) | 5508 / 94630 (5.8%) | −82.1 | −80.1 | 0.29 |
| FOXA1 SRX100477 | Hep G2 Liver | 242 / 9463 (2.6%) | 6825 / 94630 (7.2%) | −82.0 | −80.0 | 0.35 |
| ESR1 SRX1012630 | MCF-7 Breast | 70 / 9463 (0.7%) | 3827 / 94630 (4.0%) | −82.0 | −80.0 | 0.18 |
| ESR1 SRX5323874 | MCF-7 Breast | 116 / 9463 (1.2%) | 4705 / 94630 (5.0%) | −81.8 | −79.8 | 0.25 |
| ESR1 SRX20282966 | MCF-7 Breast | 63 / 9463 (0.7%) | 3672 / 94630 (3.9%) | −81.7 | −79.7 | 0.17 |
| ESR1 SRX5323876 | MCF-7 Breast | 102 / 9463 (1.1%) | 4444 / 94630 (4.7%) | −81.7 | −79.7 | 0.23 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 201 / 9463 (2.1%) | 6154 / 94630 (6.5%) | −81.6 | −79.6 | 0.33 |
| ESR1 SRX2513519 | MCF-7 Breast | 107 / 9463 (1.1%) | 4532 / 94630 (4.8%) | −81.6 | −79.6 | 0.24 |
| FOXA1 SRX5203294 | MCF-7 Breast | 51 / 9463 (0.5%) | 3411 / 94630 (3.6%) | −81.6 | −79.6 | 0.15 |
| FOXA1 SRX190181 | A549 Lung | 148 / 9463 (1.6%) | 5268 / 94630 (5.6%) | −81.6 | −79.6 | 0.28 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 309 / 9463 (3.3%) | 7831 / 94630 (8.3%) | −81.5 | −79.5 | 0.39 |
| FOXA1 SRX5323829 | T-47D Breast | 109 / 9463 (1.2%) | 4568 / 94630 (4.8%) | −81.4 | −79.4 | 0.24 |
| ESR1 SRX3110720 | MCF-7 Breast | 74 / 9463 (0.8%) | 3887 / 94630 (4.1%) | −81.3 | −79.3 | 0.19 |
| RUNX1 SRX2513054 | 293 Kidney | 1666 / 9463 (17.6%) | 10079 / 94630 (10.7%) | −81.3 | −79.3 | 1.65 |
| VGLL1 SRX24602134 | BeWo Placenta | 152 / 9463 (1.6%) | 5326 / 94630 (5.6%) | −81.3 | −79.3 | 0.29 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 485 / 9463 (5.1%) | 1637 / 94630 (1.7%) | −81.2 | −79.2 | 2.96 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 135 / 9463 (1.4%) | 5028 / 94630 (5.3%) | −81.2 | −79.2 | 0.27 |
| SMARCA4 SRX5212357 | Mel270 Others | 305 / 9463 (3.2%) | 7759 / 94630 (8.2%) | −81.1 | −79.2 | 0.39 |
| FOXA1 SRX9604647 | LNCAP Prostate | 323 / 9463 (3.4%) | 8022 / 94630 (8.5%) | −81.0 | −79.0 | 0.40 |
| ESR1 SRX1012633 | MCF-7 Breast | 101 / 9463 (1.1%) | 4397 / 94630 (4.6%) | −80.7 | −78.7 | 0.23 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 178 / 9463 (1.9%) | 5744 / 94630 (6.1%) | −80.6 | −78.6 | 0.31 |
| ZEB1 SRX13298925 | MCF-7 Breast | 126 / 9463 (1.3%) | 4851 / 94630 (5.1%) | −80.6 | −78.6 | 0.26 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 380 / 9463 (4.0%) | 8838 / 94630 (9.3%) | −80.6 | −78.6 | 0.43 |
| ZEB1 SRX13298924 | MCF-7 Breast | 95 / 9463 (1.0%) | 4276 / 94630 (4.5%) | −80.5 | −78.5 | 0.22 |
| ETS1 SRX3033231 | HEYA8 Gonad | 175 / 9463 (1.8%) | 198 / 94630 (0.2%) | −80.3 | −78.3 | 8.84 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 228 / 9463 (2.4%) | 6543 / 94630 (6.9%) | −80.3 | −78.3 | 0.35 |
| ESR1 SRX10365534 | MCF-7 Breast | 53 / 9463 (0.6%) | 3414 / 94630 (3.6%) | −80.1 | −78.1 | 0.16 |
| SMARCA4 SRX5212371 | Mel270 Others | 306 / 9463 (3.2%) | 7731 / 94630 (8.2%) | −80.0 | −78.0 | 0.40 |
| TFAP2C SRX128099 | MCF-7 Breast | 189 / 9463 (2.0%) | 5908 / 94630 (6.2%) | −80.0 | −78.0 | 0.32 |
| FOXA1 SRX5203307 | MCF-7 Breast | 52 / 9463 (0.5%) | 3388 / 94630 (3.6%) | −80.0 | −78.0 | 0.15 |
| ARID1A SRX5089382 | MCF-7 Breast | 143 / 9463 (1.5%) | 5129 / 94630 (5.4%) | −79.9 | −77.9 | 0.28 |
| ESR1 SRX2922232 | SUM 44PE Breast | 78 / 9463 (0.8%) | 3924 / 94630 (4.1%) | −79.7 | −77.8 | 0.20 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 138 / 9463 (1.5%) | 5036 / 94630 (5.3%) | −79.7 | −77.7 | 0.27 |
| ESR1 SRX1012628 | MCF-7 Breast | 101 / 9463 (1.1%) | 4361 / 94630 (4.6%) | −79.7 | −77.7 | 0.23 |
| TFAP2C SRX018833 | MCF-7 Breast | 191 / 9463 (2.0%) | 5925 / 94630 (6.3%) | −79.5 | −77.6 | 0.32 |
| RXRB SRX2636027 | Hep G2 Liver | 228 / 9463 (2.4%) | 6514 / 94630 (6.9%) | −79.5 | −77.5 | 0.35 |
| FOXA1 SRX9604645 | LNCAP Prostate | 302 / 9463 (3.2%) | 7650 / 94630 (8.1%) | −79.4 | −77.5 | 0.39 |
| SOX5 SRX2636544 | Hep G2 Liver | 213 / 9463 (2.3%) | 6273 / 94630 (6.6%) | −79.4 | −77.5 | 0.34 |
| SOX6 SRX10475370 | Hep G2 Liver | 380 / 9463 (4.0%) | 8790 / 94630 (9.3%) | −79.4 | −77.4 | 0.43 |
| ESR1 SRX2513518 | MCF-7 Breast | 98 / 9463 (1.0%) | 4298 / 94630 (4.5%) | −79.3 | −77.3 | 0.23 |
| FOXA1 SRX3931033 | MCF-7 Breast | 130 / 9463 (1.4%) | 4877 / 94630 (5.2%) | −79.2 | −77.3 | 0.27 |
| KMT2C SRX1787675 | MCF-7 Breast | 187 / 9463 (2.0%) | 5839 / 94630 (6.2%) | −79.1 | −77.1 | 0.32 |
| FOSL2 SRX190204 | A549 Lung | 214 / 9463 (2.3%) | 6276 / 94630 (6.6%) | −79.0 | −77.1 | 0.34 |
| SMARCA4 SRX8566546 | 786-O Kidney | 738 / 9463 (7.8%) | 13607 / 94630 (14.4%) | −79.0 | −77.0 | 0.54 |
| NR3C1 SRX19024866 | MCF-7 Breast | 69 / 9463 (0.7%) | 3717 / 94630 (3.9%) | −79.0 | −77.0 | 0.19 |
| STAT3 SRX5323860 | MCF-7 Breast | 267 / 9463 (2.8%) | 7101 / 94630 (7.5%) | −79.0 | −77.0 | 0.38 |
| GATAD2A SRX2636507 | Hep G2 Liver | 230 / 9463 (2.4%) | 6529 / 94630 (6.9%) | −78.9 | −77.0 | 0.35 |
| Epitope tags SRX8080559 | Mammary gland adenocarcinoma Breast | 82 / 9463 (0.9%) | 3975 / 94630 (4.2%) | −78.8 | −76.9 | 0.21 |
| VGLL1 SRX18013279 | FULVR Breast | 97 / 9463 (1.0%) | 4262 / 94630 (4.5%) | −78.8 | −76.8 | 0.23 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 422 / 9463 (4.5%) | 9365 / 94630 (9.9%) | −78.8 | −76.8 | 0.45 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 392 / 9463 (4.1%) | 8938 / 94630 (9.4%) | −78.8 | −76.8 | 0.44 |
| ESR1 SRX4451214 | MCF-7 Breast | 186 / 9463 (2.0%) | 5813 / 94630 (6.1%) | −78.7 | −76.7 | 0.32 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 225 / 9463 (2.4%) | 6437 / 94630 (6.8%) | −78.6 | −76.6 | 0.35 |
| FOXA1 SRX9550865 | Prostate cancer Prostate | 421 / 9463 (4.4%) | 9328 / 94630 (9.9%) | −78.3 | −76.3 | 0.45 |
| FOXA1 SRX3923511 | MCF-7 Breast | 71 / 9463 (0.8%) | 3739 / 94630 (4.0%) | −78.3 | −76.3 | 0.19 |
| SMARCA4 SRX15419260 | 786-O Kidney | 740 / 9463 (7.8%) | 13596 / 94630 (14.4%) | −78.2 | −76.3 | 0.54 |
| AHR SRX2378695 | MCF-7 Breast | 86 / 9463 (0.9%) | 4030 / 94630 (4.3%) | −78.1 | −76.2 | 0.21 |
| EP300 SRX100544 | Hep G2 Liver | 162 / 9463 (1.7%) | 5394 / 94630 (5.7%) | −78.1 | −76.2 | 0.30 |
| CREB1 SRX5661982 | Kidney Cortex Kidney | 458 / 9463 (4.8%) | 9839 / 94630 (10.4%) | −78.1 | −76.1 | 0.47 |
| STAT3 SRX2020843 | HCC70 Breast | 139 / 9463 (1.5%) | 4993 / 94630 (5.3%) | −77.9 | −76.0 | 0.28 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 72 / 9463 (0.8%) | 3743 / 94630 (4.0%) | −77.7 | −75.7 | 0.19 |
| FOXA1 SRX1447317 | MCF-7 Breast | 138 / 9463 (1.5%) | 4963 / 94630 (5.2%) | −77.6 | −75.6 | 0.28 |
| ESR1 SRX1012625 | MCF-7 Breast | 106 / 9463 (1.1%) | 4389 / 94630 (4.6%) | −77.5 | −75.6 | 0.24 |
| AGO2 SRX6783957 | Hep G2 Liver | 636 / 9463 (6.7%) | 2611 / 94630 (2.8%) | −77.4 | −75.5 | 2.44 |
| FOXA1 SRX1447316 | MCF-7 Breast | 84 / 9463 (0.9%) | 3973 / 94630 (4.2%) | −77.4 | −75.5 | 0.21 |
| JUNB SRX4192882 | MCF 10A Breast | 174 / 9463 (1.8%) | 5572 / 94630 (5.9%) | −77.4 | −75.4 | 0.31 |
| ESR1 SRX5089447 | MCF-7 Breast | 92 / 9463 (1.0%) | 4119 / 94630 (4.4%) | −77.3 | −75.3 | 0.22 |
| KAT7 SRX101303 | RKO Digestive tract | 693 / 9463 (7.3%) | 2985 / 94630 (3.2%) | −77.1 | −75.1 | 2.32 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 293 / 9463 (3.1%) | 682 / 94630 (0.7%) | −77.0 | −75.1 | 4.30 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1063 / 9463 (11.2%) | 5569 / 94630 (5.9%) | −77.0 | −75.1 | 1.91 |
| AHR SRX20282969 | MCF-7 Breast | 95 / 9463 (1.0%) | 4169 / 94630 (4.4%) | −77.0 | −75.1 | 0.23 |
| STAT3 SRX150479 | MCF 10A Breast | 201 / 9463 (2.1%) | 5999 / 94630 (6.3%) | −76.9 | −75.0 | 0.34 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 191 / 9463 (2.0%) | 5835 / 94630 (6.2%) | −76.9 | −75.0 | 0.33 |
| FOXA2 SRX11650945 | hESC derived pancreatic cells Pluripotent stem cell | 136 / 9463 (1.4%) | 4901 / 94630 (5.2%) | −76.6 | −74.7 | 0.28 |
| ESR1 SRX176856 | MCF-7 Breast | 67 / 9463 (0.7%) | 3610 / 94630 (3.8%) | −76.6 | −74.7 | 0.19 |
| SP1 SRX5457222 | Liver Liver | 387 / 9463 (4.1%) | 8771 / 94630 (9.3%) | −76.4 | −74.5 | 0.44 |
| FOXA1 SRX3931032 | MCF-7 Breast | 121 / 9463 (1.3%) | 4626 / 94630 (4.9%) | −76.4 | −74.5 | 0.26 |
| AR SRX1067066 | LHSAR Prostate | 464 / 9463 (4.9%) | 9848 / 94630 (10.4%) | −76.3 | −74.4 | 0.47 |
| ESR1 SRX5089450 | MCF-7 Breast | 112 / 9463 (1.2%) | 4466 / 94630 (4.7%) | −76.3 | −74.4 | 0.25 |
| NR3C1 SRX19024870 | MCF-7 Breast | 68 / 9463 (0.7%) | 3622 / 94630 (3.8%) | −76.3 | −74.4 | 0.19 |
| ZEB1 SRX13298923 | MCF-7 Breast | 88 / 9463 (0.9%) | 4015 / 94630 (4.2%) | −76.3 | −74.3 | 0.22 |
| JUN SRX883584 | MDA-MB-231 Breast | 349 / 9463 (3.7%) | 8219 / 94630 (8.7%) | −76.2 | −74.3 | 0.42 |
| KDM6A SRX15826236 | MCF-7 Breast | 61 / 9463 (0.6%) | 3473 / 94630 (3.7%) | −76.2 | −74.2 | 0.18 |
| ESR1 SRX1995230 | MCF-7 Breast | 183 / 9463 (1.9%) | 5674 / 94630 (6.0%) | −76.1 | −74.2 | 0.32 |
| RNF2 SRX18954719 | SCC-25 Others | 292 / 9463 (3.1%) | 7375 / 94630 (7.8%) | −76.1 | −74.2 | 0.40 |
| TRPS1 SRX3401273 | MCF-7 Breast | 65 / 9463 (0.7%) | 3552 / 94630 (3.8%) | −76.1 | −74.2 | 0.18 |
| Epitope tags SRX20741907 | Hep G2 Liver | 293 / 9463 (3.1%) | 7385 / 94630 (7.8%) | −76.0 | −74.1 | 0.40 |
| GATA2 SRX16314544 | Trophoblast stem cells Placenta | 139 / 9463 (1.5%) | 4929 / 94630 (5.2%) | −75.9 | −74.0 | 0.28 |
| YAP1 SRX10119364 | MCF 10A Breast | 184 / 9463 (1.9%) | 5688 / 94630 (6.0%) | −75.9 | −74.0 | 0.32 |
| FOXA1 SRX6860635 | T-47D Breast | 163 / 9463 (1.7%) | 5335 / 94630 (5.6%) | −75.8 | −73.9 | 0.31 |
| ESR1 SRX5287697 | MCF-7 Breast | 71 / 9463 (0.8%) | 3666 / 94630 (3.9%) | −75.8 | −73.9 | 0.19 |
| ESR1 SRX1469950 | MCF-7 Breast | 74 / 9463 (0.8%) | 3724 / 94630 (3.9%) | −75.7 | −73.8 | 0.20 |
| FOXA1 SRX6878603 | LNCAP Prostate | 246 / 9463 (2.6%) | 6661 / 94630 (7.0%) | −75.7 | −73.8 | 0.37 |
| CDK9 SRX7366779 | MCF-7 Breast | 127 / 9463 (1.3%) | 84 / 94630 (0.1%) | −75.6 | −73.7 | 15.12 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 120 / 9463 (1.3%) | 4583 / 94630 (4.8%) | −75.6 | −73.7 | 0.26 |
| ESR1 SRX3123823 | MCF-7 Breast | 68 / 9463 (0.7%) | 3597 / 94630 (3.8%) | −75.5 | −73.6 | 0.19 |
| JUND SRX150408 | HeLa Uterus | 195 / 9463 (2.1%) | 5850 / 94630 (6.2%) | −75.5 | −73.6 | 0.33 |
| FOXA1 SRX3923508 | MCF-7 Breast | 61 / 9463 (0.6%) | 3456 / 94630 (3.7%) | −75.5 | −73.6 | 0.18 |
| FOXA1 SRX5323846 | MCF-7 Breast | 75 / 9463 (0.8%) | 3738 / 94630 (4.0%) | −75.5 | −73.6 | 0.20 |
| STAT3 SRX150630 | MCF 10A Breast | 202 / 9463 (2.1%) | 5963 / 94630 (6.3%) | −75.4 | −73.5 | 0.34 |
| NR3C1 SRX10976921 | A549 Lung | 157 / 9463 (1.7%) | 5222 / 94630 (5.5%) | −75.4 | −73.5 | 0.30 |
| FOXA3 SRX2630190 | Hep G2 Liver | 184 / 9463 (1.9%) | 5669 / 94630 (6.0%) | −75.4 | −73.5 | 0.32 |
| ELF3 SRX825394 | CFPAC-1 Pancreas | 364 / 9463 (3.8%) | 8396 / 94630 (8.9%) | −75.3 | −73.4 | 0.43 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 183 / 9463 (1.9%) | 5643 / 94630 (6.0%) | −75.1 | −73.2 | 0.32 |
| ESR1 SRX3080213 | MCF-7 Breast | 48 / 9463 (0.5%) | 3163 / 94630 (3.3%) | −75.1 | −73.2 | 0.15 |
| SMARCC1 SRX3927288 | EOL-1 Blood | 560 / 9463 (5.9%) | 11090 / 94630 (11.7%) | −75.0 | −73.1 | 0.50 |
| CEBPA SRX4705113 | MOLM-13 Blood | 522 / 9463 (5.5%) | 10578 / 94630 (11.2%) | −75.0 | −73.1 | 0.49 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 303 / 9463 (3.2%) | 7494 / 94630 (7.9%) | −74.9 | −73.0 | 0.40 |
| Epitope tags SRX5877911 | U2OS Bone | 1093 / 9463 (11.6%) | 17817 / 94630 (18.8%) | −74.8 | −72.9 | 0.61 |
| FOXA1 SRX5323830 | T-47D Breast | 127 / 9463 (1.3%) | 4684 / 94630 (4.9%) | −74.7 | −72.9 | 0.27 |
| FOXA2 SRX11650943 | hESC derived pancreatic cells Pluripotent stem cell | 134 / 9463 (1.4%) | 4805 / 94630 (5.1%) | −74.7 | −72.8 | 0.28 |
| JUNB SRX10119386 | MCF 10A Breast | 201 / 9463 (2.1%) | 5916 / 94630 (6.3%) | −74.7 | −72.8 | 0.34 |
| RELA SRX5938177 | FaDu Others | 209 / 9463 (2.2%) | 6042 / 94630 (6.4%) | −74.6 | −72.7 | 0.35 |
| Epitope tags SRX20741925 | Hep G2 Liver | 381 / 9463 (4.0%) | 8612 / 94630 (9.1%) | −74.6 | −72.7 | 0.44 |
| STAT3 SRX150536 | MCF 10A Breast | 249 / 9463 (2.6%) | 6667 / 94630 (7.0%) | −74.5 | −72.6 | 0.37 |
| CBX3 SRX6712570 | MCF-7 Breast | 174 / 9463 (1.8%) | 5473 / 94630 (5.8%) | −74.5 | −72.6 | 0.32 |
| NR3C1 SRX1161181 | ZR-75-1 Breast | 56 / 9463 (0.6%) | 3315 / 94630 (3.5%) | −74.4 | −72.5 | 0.17 |
| TEAD4 SRX190301 | hESC H1 Pluripotent stem cell | 155 / 9463 (1.6%) | 5154 / 94630 (5.4%) | −74.4 | −72.5 | 0.30 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 55 / 9463 (0.6%) | 3296 / 94630 (3.5%) | −74.4 | −72.5 | 0.17 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 144 / 9463 (1.5%) | 4964 / 94630 (5.2%) | −74.3 | −72.4 | 0.29 |
| AGO2 SRX6783958 | Hep G2 Liver | 623 / 9463 (6.6%) | 2586 / 94630 (2.7%) | −74.3 | −72.4 | 2.41 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 383 / 9463 (4.0%) | 8627 / 94630 (9.1%) | −74.3 | −72.4 | 0.44 |
| GFP SRX6949256 | HeLa Uterus | 242 / 9463 (2.6%) | 6544 / 94630 (6.9%) | −74.2 | −72.4 | 0.37 |
| SP1 SRX5457221 | Liver Liver | 275 / 9463 (2.9%) | 7048 / 94630 (7.4%) | −74.2 | −72.3 | 0.39 |
| OTX2 SRX702045 | hESC HUES64 Pluripotent stem cell | 164 / 9463 (1.7%) | 5297 / 94630 (5.6%) | −74.1 | −72.3 | 0.31 |
| GFP SRX5417098 | HeLa Uterus | 260 / 9463 (2.7%) | 6818 / 94630 (7.2%) | −74.1 | −72.2 | 0.38 |
| CEBPB SRX2194250 | SUM 159PT Breast | 268 / 9463 (2.8%) | 6937 / 94630 (7.3%) | −74.1 | −72.2 | 0.39 |
| ESR1 SRX1012631 | MCF-7 Breast | 94 / 9463 (1.0%) | 4064 / 94630 (4.3%) | −74.1 | −72.2 | 0.23 |
| FOXA2 SRX11650947 | hESC derived pancreatic cells Pluripotent stem cell | 147 / 9463 (1.6%) | 5007 / 94630 (5.3%) | −74.1 | −72.2 | 0.29 |
| FOS SRX3322636 | MCF-7 Breast | 153 / 9463 (1.6%) | 5108 / 94630 (5.4%) | −74.0 | −72.1 | 0.30 |
| RAD21 SRX2630359 | Liver Liver | 534 / 9463 (5.6%) | 10696 / 94630 (11.3%) | −73.9 | −72.0 | 0.50 |
| RXRA SRX5457468 | Liver Liver | 309 / 9463 (3.3%) | 7543 / 94630 (8.0%) | −73.9 | −72.0 | 0.41 |
| TRPS1 SRX6098145 | MCF-7 Breast | 42 / 9463 (0.4%) | 2995 / 94630 (3.2%) | −73.8 | −71.9 | 0.14 |
| VGLL1 SRX18013278 | FULVR Breast | 105 / 9463 (1.1%) | 4253 / 94630 (4.5%) | −73.7 | −71.8 | 0.25 |
| FOXA1 SRX190282 | A549 Lung | 161 / 9463 (1.7%) | 5229 / 94630 (5.5%) | −73.7 | −71.8 | 0.31 |
| PBX3 SRX190343 | SK-N-SH Neural | 478 / 9463 (5.1%) | 9923 / 94630 (10.5%) | −73.5 | −71.7 | 0.48 |
| FOXA1 SRX15391842 | T-47D Breast | 120 / 9463 (1.3%) | 4519 / 94630 (4.8%) | −73.5 | −71.7 | 0.27 |
| NKX2-1 SRX2164786 | A549 Lung | 374 / 9463 (4.0%) | 8469 / 94630 (8.9%) | −73.5 | −71.6 | 0.44 |
| FOXA1 SRX1161207 | T-47D Breast | 87 / 9463 (0.9%) | 3910 / 94630 (4.1%) | −73.5 | −71.6 | 0.22 |
| FOXA1 SRX1161205 | T-47D Breast | 116 / 9463 (1.2%) | 4444 / 94630 (4.7%) | −73.5 | −71.6 | 0.26 |
| JUN SRX6582171 | GM07492 Others | 438 / 9463 (4.6%) | 9367 / 94630 (9.9%) | −73.5 | −71.6 | 0.47 |
| FOXA1 SRX15431000 | T-47D Breast | 179 / 9463 (1.9%) | 5518 / 94630 (5.8%) | −73.4 | −71.6 | 0.32 |
| ZNF219 SRX3230413 | Hep G2 Liver | 382 / 9463 (4.0%) | 8581 / 94630 (9.1%) | −73.4 | −71.5 | 0.45 |
| CREB1 SRX5661984 | Kidney Cortex Kidney | 439 / 9463 (4.6%) | 9379 / 94630 (9.9%) | −73.4 | −71.5 | 0.47 |
| ESR1 SRX8537719 | SUM 44PE Breast | 136 / 9463 (1.4%) | 4794 / 94630 (5.1%) | −73.4 | −71.5 | 0.28 |
| ESR1 SRX7624162 | T-47D Breast | 121 / 9463 (1.3%) | 4529 / 94630 (4.8%) | −73.3 | −71.5 | 0.27 |
| FOXA1 SRX3931056 | MCF-7 Breast | 131 / 9463 (1.4%) | 4704 / 94630 (5.0%) | −73.3 | −71.4 | 0.28 |
| TP53 SRX3102569 | SW 480 Digestive tract | 436 / 9463 (4.6%) | 9331 / 94630 (9.9%) | −73.3 | −71.4 | 0.47 |
| EP300 SRX2671813 | Fibroblasts Others | 195 / 9463 (2.1%) | 5765 / 94630 (6.1%) | −73.1 | −71.2 | 0.34 |
| FOXA2 SRX11650946 | hESC derived pancreatic cells Pluripotent stem cell | 113 / 9463 (1.2%) | 4380 / 94630 (4.6%) | −73.0 | −71.2 | 0.26 |
| ESR1 SRX371446 | Tumour tissues Others | 234 / 9463 (2.5%) | 6378 / 94630 (6.7%) | −73.0 | −71.2 | 0.37 |
| FOXA1 SRX1787654 | MCF-7 Breast | 77 / 9463 (0.8%) | 3703 / 94630 (3.9%) | −72.9 | −71.1 | 0.21 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 243 / 9463 (2.6%) | 6514 / 94630 (6.9%) | −72.9 | −71.1 | 0.37 |
| EP300 SRX2194265 | SUM 159PT Breast | 363 / 9463 (3.8%) | 8290 / 94630 (8.8%) | −72.9 | −71.1 | 0.44 |
| ESR1 SRX5534832 | MCF-7 Breast | 202 / 9463 (2.1%) | 5865 / 94630 (6.2%) | −72.8 | −70.9 | 0.34 |
| FOXA1 SRX9550895 | Prostate cancer Prostate | 226 / 9463 (2.4%) | 6244 / 94630 (6.6%) | −72.7 | −70.9 | 0.36 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 440 / 9463 (4.6%) | 9364 / 94630 (9.9%) | −72.7 | −70.9 | 0.47 |
| EP300 SRX2671820 | iPS cells Pluripotent stem cell | 48 / 9463 (0.5%) | 3098 / 94630 (3.3%) | −72.6 | −70.8 | 0.15 |
| JUNB SRX8488074 | SUM 229PE Breast | 306 / 9463 (3.2%) | 7446 / 94630 (7.9%) | −72.6 | −70.7 | 0.41 |
| MITF SRX7368255 | Hermes 3C Epidermis | 645 / 9463 (6.8%) | 12091 / 94630 (12.8%) | −72.4 | −70.5 | 0.53 |
| CREB1 SRX5661983 | Kidney Cortex Kidney | 444 / 9463 (4.7%) | 9397 / 94630 (9.9%) | −72.2 | −70.3 | 0.47 |
| CEBPB SRX3584202 | Epididymis Gonad | 214 / 9463 (2.3%) | 6031 / 94630 (6.4%) | −72.1 | −70.2 | 0.35 |
| ESR1 SRX20282944 | MCF-7 Breast | 28 / 9463 (0.3%) | 2618 / 94630 (2.8%) | −72.0 | −70.2 | 0.11 |
| ESR1 SRX5323875 | MCF-7 Breast | 77 / 9463 (0.8%) | 3675 / 94630 (3.9%) | −72.0 | −70.2 | 0.21 |
| TEAD1 SRX1011298 | HuCCT1 Liver | 94 / 9463 (1.0%) | 3998 / 94630 (4.2%) | −72.0 | −70.2 | 0.24 |
| ESR1 SRX3554403 | MDA-MB-134-VI Breast | 100 / 9463 (1.1%) | 4111 / 94630 (4.3%) | −72.0 | −70.1 | 0.24 |
| TLE3 SRX4815194 | SUM 149PT Breast | 175 / 9463 (1.8%) | 5405 / 94630 (5.7%) | −72.0 | −70.1 | 0.32 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 443 / 9463 (4.7%) | 9367 / 94630 (9.9%) | −71.8 | −70.0 | 0.47 |
| FOSL2 SRX10475315 | Hep G2 Liver | 252 / 9463 (2.7%) | 6605 / 94630 (7.0%) | −71.7 | −69.9 | 0.38 |
| ESR1 SRX3123830 | MCF-7 Breast | 57 / 9463 (0.6%) | 3261 / 94630 (3.4%) | −71.7 | −69.9 | 0.17 |
| STAT3 SRX2020847 | MDA-MB-468 Breast | 163 / 9463 (1.7%) | 5195 / 94630 (5.5%) | −71.7 | −69.8 | 0.31 |
| NKX2-1 SRX366169 | NCI-H441 Lung | 278 / 9463 (2.9%) | 7000 / 94630 (7.4%) | −71.7 | −69.8 | 0.40 |
| ESRRA SRX1473610 | BT-474 Breast | 124 / 9463 (1.3%) | 4527 / 94630 (4.8%) | −71.6 | −69.8 | 0.27 |
| GRHL2 SRX268451 | Tracheal epithelial cells Lung | 145 / 9463 (1.5%) | 4893 / 94630 (5.2%) | −71.6 | −69.8 | 0.30 |
| ESR1 SRX7624161 | T-47D Breast | 129 / 9463 (1.4%) | 4615 / 94630 (4.9%) | −71.5 | −69.7 | 0.28 |
| FOXA2 SRX6441751 | CFPAC-1 Pancreas | 103 / 9463 (1.1%) | 4151 / 94630 (4.4%) | −71.5 | −69.6 | 0.25 |
| ESR1 SRX20282967 | MCF-7 Breast | 62 / 9463 (0.7%) | 3361 / 94630 (3.6%) | −71.5 | −69.6 | 0.18 |
| CBX3 SRX190214 | HCT 116 Digestive tract | 399 / 9463 (4.2%) | 8739 / 94630 (9.2%) | −71.5 | −69.6 | 0.46 |
| MAU2 SRX11120892 | MCF-7 Breast | 90 / 9463 (1.0%) | 3906 / 94630 (4.1%) | −71.4 | −69.6 | 0.23 |
Showing first 500 of 15914 rows.